抑制素A/Inhibin α抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 抑制素A/Inhibin α抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

The inhibin alpha subunit joins either the beta A or beta B subunit to form a pituitary FSH secretion inhibitor. Inhibin has been shown to regulate gonadal stromal cell proliferation negatively and to have tumour-suppressor activity. In addition, serum levels of inhibin have been shown to reflect the size of granulosa-cell tumors and can therefore be抑制素A/Inhibin α抗体 used as a marker for primary as well as recurrent disease. However, in prostate cancer, expression of the inhibin alpha-subunit gene was suppressed and was not detectable in poorly differentiated tumor cells. Furthermore, because expression in gonadal and various extragonadal抑制素A/Inhibin α抗体 tissues may vary severalfold in a tissue-specific fashion, it is proposed that inhibin may be both a growth/differentiation factor and a hormone.

Also known as:

A inhibin subunit precursor; IHA; INHA; Inhibin alpha chain; Inhibin alpha chain precursor; Inhibin alpha subunit; INHA_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG,抑制素A/Inhibin α抗体 affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep, Monkey, .

●

Immunogen: KLH conjugated synthetic peptide derived from human Inhibin .

●

Predicted Molecular Weight: 15kDa.

抑制素A/Inhibin α抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl778Mu01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)

kl778Po01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)

kl778Ra01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)

kl781Hu01CD276分子(CD276)多克隆抗体Polyclonal Antibody to Cluster Of Differentiation 276 (CD276)

kl782Ga01碳酸酐酶Ⅱ(CA2)多克隆抗体Polyclonal Antibody to Carbonic Anhydrase II (CA2)

kl782Hu01碳酸酐酶Ⅱ(CA2)多克隆抗体Polyclonal Antibody to Carbonic Anhydrase II (CA2)

kl783Hu01补体因子P(CFP)多克隆抗体Polyclonal Antibody to Complement Factor P (CFP)

kl785Hu01肾损伤分子1(Kim1)多克隆抗体Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)

kl785Mu01肾损伤分子1(Kim1)多克隆抗体Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)

kl785Ra01肾损伤分子1(Kim1)多克隆抗体Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)

kl786Hu01纤维胶凝蛋白1(FCN1)多克隆抗体Polyclonal Antibody to Ficolin 1 (FCN1)

kl786Mu01纤维胶凝蛋白1(FCN1)多克隆抗体Polyclonal Antibody to Ficolin 1 (FCN1)

kl788Hu01细胞程序性死亡蛋白1配体1(PDCD1LG1)多克隆抗体Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)

kl788Mu01细胞程序性死亡蛋白1配体1(PDCD1LG1)多克隆抗体Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)

kl791Mu01骨粘连蛋白(ON)多克隆抗体Polyclonal Antibody to Osteonectin (ON)

kl791Ra01骨粘连蛋白(ON)多克隆抗体Polyclonal Antibody to Osteonectin (ON)

kl792Hu01拓扑异构酶Ⅱ(TOP2)多克隆抗体Polyclonal Antibody to Topoisomerase II (TOP2)

kl794Hu01周期素依赖性激酶抑制因子2A(CDKN2A)多克隆抗体Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

kl794Mu01周期素依赖性激酶抑制因子2A(CDKN2A)多克隆抗体Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

kl796Hu01神经肽S(NPS)多克隆抗体Polyclonal Antibody to Neuropeptide S (NPS)

kl796Mu01神经肽S(NPS)多克隆抗体Polyclonal Antibody to Neuropeptide S (NPS)

kl796Ra01神经肽S(NPS)多克隆抗体Polyclonal Antibody to Neuropeptide S (NPS)

kl797Hu01血管紧张素原(AGT)多克隆抗体Polyclonal Antibody to Angiotensinogen (AGT)

kl797Mu01血管紧张素原(AGT)多克隆抗体Polyclonal Antibody to Angiotensinogen (AGT)

kl797Ra01血管紧张素原(AGT)多克隆抗体Polyclonal Antibody to Angiotensinogen (AGT)